Recent News

• 05.16.2025 - CAMP4 Presents Translational Data from SYNGAP1-Related Disorders Program Showcasing Increased Protein in Non-Human Primates and Reviews Preclinical and Detailed Single Ascending Dose Safety Data from Urea Cycle Disorders Program at the 28th American Society of Gene and Cell Therapy Annual Meeting
• 05.16.2025 - CAMP4 Presents Translational Data from SYNGAP1-Related Disorders Program Showcasing Increased Protein in Non-Human Primates and Reviews Preclinical and Detailed Single Ascending Dose Safety Data from Urea Cycle Disorders Program at the 28th American Society of Gene and Cell Therapy Annual Meeting
• 05.16.2025 - 28th Annual American Society of Gene and Cell Therapy (ASGCT) Meeting
• 05.16.2025 - 28th Annual American Society of Gene and Cell Therapy (ASGCT) Meeting
• 05.13.2025 - CAMP4 Reports First Quarter 2025 Financial Results and Corporate Highlights
• 05.13.2025 - CAMP4 Reports First Quarter 2025 Financial Results and Corporate Highlights
• 04.28.2025 - CAMP4 to Present New Preclinical Data from its Urea Cycle Disorders and SYNGAP1-Related Disorders Programs at the 28th American Society of Gene and Cell Therapy Annual Meeting
• 04.28.2025 - CAMP4 to Present New Preclinical Data from its Urea Cycle Disorders and SYNGAP1-Related Disorders Programs at the 28th American Society of Gene and Cell Therapy Annual Meeting
• 04.09.2025 - 24th Annual Needham Virtual Healthcare Conference
• 04.09.2025 - 24th Annual Needham Virtual Healthcare Conference

Recent Filings

• 05.16.2025 - EX-99.1 EX-99.1
• 05.16.2025 - 8-K Current report
• 05.14.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 05.13.2025 - 8-K Current report
• 05.13.2025 - EX-99.1 EX-99.1
• 05.13.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 04.30.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 04.30.2025 - ARS Annual Report to Security Holders
• 04.30.2025 - DEF 14A Other definitive proxy statements
• 04.11.2025 - 3/A Initial statement of beneficial ownership of securities